Evidence map›Paper›PMID 24274985›Full record

ArticleEndocrinology2014

17β-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice.

Marilyn K Glassberg, Rhea Choi, Vita Manzoli, Shahriar Shahzeidi, Peter Rauschkolb, Robert Voswinckel, Muddassir Aliniazee, Xiaomei Xia, Sharon J Elliot

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Catalase, a therapeutic target in the reversal of estrogen-mediated aging.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marilyn K GlassbergDepartments of Pulmonary and Critical Care Medicine (M.K.G., R.C., S.S., M.A.) and Surgery (X.X., S.J.E.) and the Diabetes Research Institute (V.M.), University of Miami Miller School of Medicine, Miami, Florida 33137; and Department for Lung Development and Remodeling (P.R., R.V.), Max-Planck-Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
Rhea Choi
Vita Manzoli
Shahriar Shahzeidi
Peter Rauschkolb
Robert Voswinckel
Muddassir Aliniazee
Xiaomei Xia
Sharon J Elliot
University of Miami · USMax Planck Institute for Heart and Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role that estrogens play in the aging lung is poorly understood. Remodeling of the aging lung with thickening of the alveolar walls and reduction in the number of peripheral airways is well recognized. The present study was designed to address whether estrogen deficiency would affect age-associated changes in the lungs of female C57BL/6J mice. Lungs isolated from old mice (24 months old, estrogen-deficient) demonstrated decreased lung volume and decreased alveolar surface area. There was no difference in alveolar number in the lungs of old and young mice (6 months old, estrogen-replete). Estrogen replacement restored lung volume, alveolar surface area, and alveolar wall thickness to that of a young mouse. Estrogen receptor-α (ERα) protein expression increased without a change in ERβ protein expression in the lung tissue isolated from old mice. In the lungs of old mice, the number of apoptotic cells was increased as well as the activation of matrix metalloproteinase-2 and ERK. Young mice had the highest serum 17β-estradiol levels that decreased with age. Our data suggest that in the aging female mouse lung, estrogen deficiency and an increase of ERα expression lead to the development of an emphysematous phenotype. Estrogen replacement partially prevents these age-associated changes in the lung architecture by restoration of interalveolar septa. Understanding the role of estrogens in the remodeling of the lung during aging may facilitate interventions and therapies for aging-related lung disease in women.

Indexed as

Estrogen Replacement TherapyAgingAnimalsApoptosisEstradiolEstrogen Receptor alphaFemaleLungLung DiseasesMatrix Metalloproteinase 2MiceMice, Inbred C57BLOrgan SizeOvariectomyRNA, MessengerEstradiolEstrogen Receptor alphaMatrix Metalloproteinase 2RNA, Messenger

Identifiers

PMID24274985
PMCPMC3891937
OpenAlexW1970520109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.